Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (SHA:600671)

SHA:600671 Revenue

Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd had revenue of 44.39M CNY in the quarter ending March 31, 2026, a decrease of -15.12%. This brings the company's revenue in the last twelve months to 203.85M, down -15.71% year-over-year. In the year 2025, Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd had annual revenue of 211.75M, down -2.55%.

• Revenue (ttm): 203.85M
• Revenue Growth: -15.71%
• P/S Ratio: 10.73
• Revenue / Employee: 520.02K
• Employees: 392
• Market Cap: 2.19B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	211.75M	-5.54M	-2.55%
Dec 31, 2024	217.30M	95.52M	78.44%
Dec 31, 2023	121.78M	12.87M	11.82%
Dec 31, 2022	108.91M	-38.16M	-25.95%
Dec 31, 2021	147.07M	-59.56M	-28.82%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 15, 2026

Data Sources Report a data error